270 related articles for article (PubMed ID: 37114037)
1. Construction of a novel molecular typing and scoring system for anoikis distinguishes between different prognostic risks and treatment responsiveness in low-grade glioma.
Zhang G; Chen A; Fang J; Wu A; Chen G; Tai P; Chen H; Chen X; Cao K
Front Immunol; 2023; 14():1105210. PubMed ID: 37114037
[TBL] [Abstract][Full Text] [Related]
2. Intrinsic immune evasion patterns predict temozolomide sensitivity and immunotherapy response in lower-grade gliomas.
Tu Z; Ji Q; Han Q; Long X; Li J; Wu L; Huang K; Zhu X
BMC Cancer; 2022 Sep; 22(1):973. PubMed ID: 36096781
[TBL] [Abstract][Full Text] [Related]
3. Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy.
Teng C; Zhu Y; Li Y; Dai L; Pan Z; Wanggou S; Li X
Front Immunol; 2022; 13():899710. PubMed ID: 35677036
[TBL] [Abstract][Full Text] [Related]
4. Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma.
Li J; Guo Q; Xing R
BMC Cancer; 2023 Aug; 23(1):727. PubMed ID: 37543576
[TBL] [Abstract][Full Text] [Related]
5. Positive regulators of T cell functions as predictors of prognosis and microenvironment characteristics of low-grade gliomas.
Li Y; Feng Y; Luo F; Peng G; Li Y
Front Immunol; 2022; 13():1089792. PubMed ID: 36726969
[TBL] [Abstract][Full Text] [Related]
6. Molecular subtypes based on centrosome-related genes can predict prognosis and therapeutic responsiveness in patients with low-grade gliomas.
Zhang G; Tai P; Fang J; Chen A; Chen X; Cao K
Front Oncol; 2023; 13():1157115. PubMed ID: 37051542
[TBL] [Abstract][Full Text] [Related]
7. Identification of anoikis related subtypes and construction of prognostic model in hepatocellular carcinoma.
Fang W; Chen Z
Cell Mol Biol (Noisy-le-grand); 2023 Sep; 69(9):219-228. PubMed ID: 37807308
[TBL] [Abstract][Full Text] [Related]
8. Cuprotosis clusters predict prognosis and immunotherapy response in low-grade glioma.
Zhu W; Chen Z; Fu M; Li Q; Chen X; Li X; Luo N; Tang W; Yang F; Zhang Y; Zhang Y; Peng X; Hu G
Apoptosis; 2024 Feb; 29(1-2):169-190. PubMed ID: 37713112
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation of a risk model and molecular subtypes based on tryptophan metabolism-related genes to predict the clinical prognosis and tumor immune microenvironment in lower-grade glioma.
Li W; Ling L; Xiang L; Ding P; Yue W
Front Cell Neurosci; 2023; 17():1146686. PubMed ID: 36925967
[TBL] [Abstract][Full Text] [Related]
10. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
[TBL] [Abstract][Full Text] [Related]
11. A Bioinformatics-Based Analysis of an Anoikis-Related Gene Signature Predicts the Prognosis of Patients with Low-Grade Gliomas.
Zhao S; Chi H; Ji W; He Q; Lai G; Peng G; Zhao X; Cheng C
Brain Sci; 2022 Oct; 12(10):. PubMed ID: 36291283
[TBL] [Abstract][Full Text] [Related]
12. The Comprehensive Analysis of m6A-Associated Anoikis Genes in Low-Grade Gliomas.
Zheng H; Zhao Y; Zhou H; Tang Y; Xie Z
Brain Sci; 2023 Sep; 13(9):. PubMed ID: 37759912
[TBL] [Abstract][Full Text] [Related]
13. Anoikis-related gene signatures in colorectal cancer: implications for cell differentiation, immune infiltration, and prognostic prediction.
Ding T; Shang Z; Zhao H; Song R; Xiong J; He C; Liu D; Yi B
Sci Rep; 2024 May; 14(1):11525. PubMed ID: 38773226
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of an anoikis-associated gene signature to predict clinical character, stemness, IDH mutation, and immune filtration in glioblastoma.
Sun Z; Zhao Y; Wei Y; Ding X; Tan C; Wang C
Front Immunol; 2022; 13():939523. PubMed ID: 36091049
[TBL] [Abstract][Full Text] [Related]
15. Multi-Omics Data Integration Analysis of an Immune-Related Gene Signature in LGG Patients With Epilepsy.
Cheng Q; Duan W; He S; Li C; Cao H; Liu K; Ye W; Yuan B; Xia Z
Front Cell Dev Biol; 2021; 9():686909. PubMed ID: 34336837
[TBL] [Abstract][Full Text] [Related]
16. Identification of Iron Metabolism-Related Genes as Prognostic Indicators for Lower-Grade Glioma.
Xu S; Wang Z; Ye J; Mei S; Zhang J
Front Oncol; 2021; 11():729103. PubMed ID: 34568059
[TBL] [Abstract][Full Text] [Related]
17. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
18. CCR5 as a Prognostic Factor in Lower-Grade Glioma is Involved in the Remodeling of the Tumor Microenvironment.
Wang F; Tao Z; Tian Z; Jin J; Dong J; Dai Y; Yu W; Tang B; Hu S
Front Genet; 2022; 13():874896. PubMed ID: 35865011
[No Abstract] [Full Text] [Related]
19. Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma.
Cai J; Hu Y; Ye Z; Ye L; Gao L; Wang Y; Sun Q; Tong S; Yang J; Chen Q
Front Immunol; 2022; 13():1011757. PubMed ID: 36325335
[TBL] [Abstract][Full Text] [Related]
20. Establishment of three heterogeneous subtypes and a risk model of low-grade gliomas based on cell senescence-related genes.
Chen J; Wu L; Yang H; Zhang X; Xv S; Qian Q
Front Immunol; 2022; 13():982033. PubMed ID: 36052073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
